Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -37.81%108.68M | -41.09%309.94M | -18.90%174.76M | 161.12%526.12M | 98.32%215.47M | -31.20%201.49M | -56.30%108.65M | -37.35%292.87M | 50.66%248.61M | 69.90%467.5M |
| Operating income | -37.81%108.68M | -41.09%309.94M | -18.90%174.76M | 161.12%526.12M | 98.32%215.47M | -31.20%201.49M | -56.30%108.65M | -37.35%292.87M | 50.66%248.61M | 69.90%467.5M |
| Cost of sales | 37.27%-106.5M | 40.96%-304.75M | 18.82%-169.78M | -159.79%-516.17M | -98.74%-209.15M | 30.89%-198.69M | 56.15%-105.24M | 37.62%-287.47M | -49.50%-239.97M | -70.18%-460.82M |
| Operating expenses | 37.27%-106.5M | 40.96%-304.75M | 18.82%-169.78M | -159.79%-516.17M | -98.74%-209.15M | 30.89%-198.69M | 56.15%-105.24M | 37.62%-287.47M | -49.50%-239.97M | -70.18%-460.82M |
| Gross profit | -56.14%2.18M | -47.82%5.19M | -21.28%4.98M | 255.09%9.95M | 85.30%6.33M | -48.12%2.8M | -60.48%3.41M | -19.13%5.4M | 91.94%8.64M | 52.11%6.68M |
| Selling expenses | 28.00%-1.18M | 30.95%-2.71M | -2.77%-1.63M | -90.61%-3.92M | -12.23%-1.59M | 8.95%-2.06M | 29.57%-1.42M | -10.15%-2.26M | -122.97%-2.01M | -186.31%-2.05M |
| Administrative expenses | -3.36%-1.32M | 14.79%-2.44M | 9.03%-1.28M | -22.21%-2.87M | -21.63%-1.41M | 10.15%-2.35M | 16.17%-1.16M | -28.49%-2.61M | -62.24%-1.38M | 25.57%-2.03M |
| Impairment and provision | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.32M | ---- | ---- |
| -Other impairment is provision | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.32M | ---- | ---- |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | 18.91%-446K | 41.95%-1.01M | ---550K | ---1.73M |
| Special items of operating profit | 5.91%269K | 63.54%749K | -0.39%254K | 263.49%458K | 828.57%255K | 72.60%126K | 98.79%-35K | -54.66%73K | -289,500.00%-2.89M | --161K |
| Operating profit | -101.89%-44K | -78.16%790K | -35.24%2.32M | 345.29%3.62M | 890.88%3.59M | 14.29%-1.48M | -79.97%362K | -268.40%-1.72M | -34.31%1.81M | 256.75%1.02M |
| Financing cost | 36.54%-370K | -6.98%-1.06M | -50.26%-583K | -33.29%-989K | ---388K | ---742K | ---- | ---- | ---- | ---- |
| Share of profits of associates | 75.00%-1K | 40.00%-6K | 33.33%-4K | -42.86%-10K | 14.29%-6K | 56.25%-7K | 22.22%-7K | -145.71%-16K | -800.00%-9K | 369.23%35K |
| Earning before tax | -123.91%-415K | -110.46%-274K | -45.63%1.74M | 217.76%2.62M | 799.44%3.19M | -28.04%-2.22M | -80.26%355K | -264.33%-1.74M | 37.46%1.8M | 134.30%1.06M |
| Tax | 93.31%-22K | 78.09%-55K | 2.37%-329K | -12,650.00%-251K | -99.41%-337K | 104.55%2K | 73.55%-169K | 79.34%-44K | -146.72%-639K | -610.00%-213K |
| After-tax profit from continuing operations | -131.06%-437K | -113.89%-329K | -50.74%1.41M | 206.57%2.37M | 1,435.48%2.86M | -24.76%-2.22M | -83.95%186K | -311.02%-1.78M | 10.49%1.16M | 127.12%844K |
| Earning after tax | -131.06%-437K | -113.89%-329K | -50.74%1.41M | 206.57%2.37M | 1,435.48%2.86M | -24.76%-2.22M | -83.95%186K | -311.02%-1.78M | 10.49%1.16M | 108.38%844K |
| Minority shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --26K |
| Minority shareholders should account for non-continuing business profits | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 81.43%-13K |
| Minority profit | -521.43%-87K | -740.00%-42K | -216.67%-14K | 94.19%-5K | 122.22%12K | -2,966.67%-86K | -3.85%-54K | -76.92%3K | -300.00%-52K | 118.57%13K |
| Shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 126.29%818K |
| Shareholders should account for profits from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 100.19%13K |
| Profit attributable to shareholders | -124.63%-350K | -112.09%-287K | -50.04%1.42M | 211.10%2.37M | 1,085.00%2.84M | -19.73%-2.14M | -80.18%240K | -314.68%-1.78M | 14.03%1.21M | 108.31%831K |
| Basic earnings per share | -125.00%-0.0001 | -116.67%-0.0001 | -42.86%0.0004 | 220.00%0.0006 | 600.00%0.0007 | -25.00%-0.0005 | -66.67%0.0001 | -300.00%-0.0004 | 0.00%0.0003 | 108.00%0.0002 |
| Diluted earnings per share | -125.00%-0.0001 | -116.67%-0.0001 | -42.86%0.0004 | 220.00%0.0006 | 600.00%0.0007 | -25.00%-0.0005 | -66.67%0.0001 | -300.00%-0.0004 | 0.00%0.0003 | 108.00%0.0002 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.